#CovidVaccineUpdate | Moderna signs deal with COVAX for the supply of 500 million COVID-19 vaccine doses to lowest-income countries.
https://www.moneycontrol.com/news/world/moderna-signs-deal-with-covax-for-supply-of-500-million-covid-19-vaccine-doses-to-lowest-income-countries-6849671.html
#Moderna #vaccine #WHO
https://www.moneycontrol.com/news/world/moderna-signs-deal-with-covax-for-supply-of-500-million-covid-19-vaccine-doses-to-lowest-income-countries-6849671.html
#Moderna #vaccine #WHO
Moneycontrol
Moderna Signs Deal With COVAX For Supply Of 500 Million COVID-19 Vaccine Doses To Lowest Income Countries
The Moderna vaccine turned eligible for COVAX supplies after the World Health Organisation (WHO) issued an emergency use listing on April 30.
#CovidVaccineUpdate | The UP govt has amended its global tender for #Covid19 vaccines issued last week to make the vaccine storage conditions flexible. The amendment has made companies like Pfizer and Moderna eligible to place bids.
Read more at 👇
https://www.moneycontrol.com/news/trends/covid-19-up-govt-amends-global-vaccine-tender-to-make-pfizer-moderna-eligible-chinese-firms-need-centres-nod-6899481.html
#BharatBiotech #CovidVaccine #DrReddysLaboratories #Moderna #Pfizer #SerumInstitute #UP
Read more at 👇
https://www.moneycontrol.com/news/trends/covid-19-up-govt-amends-global-vaccine-tender-to-make-pfizer-moderna-eligible-chinese-firms-need-centres-nod-6899481.html
#BharatBiotech #CovidVaccine #DrReddysLaboratories #Moderna #Pfizer #SerumInstitute #UP
Moneycontrol
COVID-19 | UP govt amends Vaccine Tender To Make Pfizer, Moderna Eligible; Chinese Firms Need Centre’s Nod
Global tenders for vaccines issued by the Uttarakhand government and Mumbai’s civic body had also specifically barred companies from neighbouring countries.
#Covid19VaccineUpdate | Moderna exceeded Wall Street's expectations reaping a windfall in the Q2, raking in a profit of Rs $2.8 billion against sales of $4.4 billion in Q2CY2021.
Viswanath Pilla reports
https://www.moneycontrol.com/news/business/companies/moderna-makes-windfall-in-q2cy21-on-covid-19-mrna-vaccine-will-the-jab-come-to-india-7289771.html
#coronavirus #Covid19 #Moderna
Viswanath Pilla reports
https://www.moneycontrol.com/news/business/companies/moderna-makes-windfall-in-q2cy21-on-covid-19-mrna-vaccine-will-the-jab-come-to-india-7289771.html
#coronavirus #Covid19 #Moderna
Moneycontrol
Moderna Makes Windfall In Q2CY21 On COVID-19 MRNA Vaccine, Will The Jab Come To India?
On the capacity front in 2021, Moderna expects to produce 800 million to 1 billion doses, and 2022 it plans to triple that capacity.
#COVID19: Vaccines developed by #Pfizer and #Moderna may not be as effective against the #DeltaVariant compared to as they were against the original strain of the virus: Study.
https://www.moneycontrol.com/news/trends/health-trends/moderna-76-effective-against-delta-pfizer-42-study-7324941.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/trends/health-trends/moderna-76-effective-against-delta-pfizer-42-study-7324941.html?utm_source=telegram&utm_medium=social
Moneycontrol
COVID-19 | Moderna 76% Effective Against Delta Variant, Pfizer 42%: Study
From January to June, the vaccines as claimed remained effective around 90 per cent, but began dipping in June and largely dropped in July as the variant took hold in the US.
#COVID19 | Centres of Disease Control and Prevention said that the efficacy of the third doses of the #Pfizer and #Moderna mRNA vaccines starts falling by the 4th month after being administered.
Read more at 👇
https://www.moneycontrol.com/news/trends/health-trends/new-cdc-study-shows-major-drop-in-efficacy-of-booster-shots-after-fourth-month-report-8083101.html?utm_source=telegram&utm_medium=social
Read more at 👇
https://www.moneycontrol.com/news/trends/health-trends/new-cdc-study-shows-major-drop-in-efficacy-of-booster-shots-after-fourth-month-report-8083101.html?utm_source=telegram&utm_medium=social
Moneycontrol
New CDC study shows major drop in efficacy of booster shots after fourth month: Report
The CDC also highlighted that this new finding indicates that additional dose or a fourth dose may be required to enhance protection.